Go to Brazil Program
Before you spend a cent, know exactly where you're going
What is the Go-to-Brazil Program
The Go-to-Brazil Program is a complete market entry diagnostic for Brazil. In 6 to 10 weeks, we map all the regulatory, technical, and commercial gaps for your product and deliver a market entry plan with a timeline, budget, and concrete next steps. It's not theory: it's the map of the territory before you invest in the land.
Knowledge
You are about to enter Brazil without knowing which segment has the most potential for your product.
Distribution
Have you heard stories of manufacturers who chose the wrong distributor and lost 2 years of runway?.
Regulation
You don't know if ANVISA's requirements for your product are simple or complex, and that worries you.
Board
You are under pressure to show a convincing entry plan to the board or investors.
Do you recognize any of these situations?
Whoever enters Brazil the right way in 2026 sets the market reference price for years to come. Those who enter on the wrong path pay to discover the right one.“
What We Do
| ✓ Complete regulatory analysis: risk classification, type of ANVISA application and realistic timeframe ✓ Gap technical analysis: what's missing from the performance data for the Brazilian dossier ✓ Market sizing by segment: potential volume, current penetration and level of competition ✓ Qualifying distributors: shortlist with 7-criteria scorecard ✓ Competitive analysis: registered products, positioning and competitors' blind spots ✓ Mapping KOLs: segment influencers that matter for adoption ✓ Evaluation of non-consumers: segments with pent-up demand that no competitor works with |
What you get
| ✓ Regulatory, technical and commercial Gap Analysis Report ✓ Market Map with Sizing by Segment and Competition Level ✓ Distributor qualification scorecard (shortlist) ✓ Entry plan with timetable, budget and decision milestones ✓ Competitive radar with positioning of the main competitors ✓ Recommendation of priority segment with quantified justification |
“Entering Brazil without a strategic diagnosis is like operating without anesthesia: painful, expensive and avoidable.”
